] cyt than cells from patients with SPH and nonpulmonary hypertension disease. Consistently, PPH-PASMCs had a more depolarized E m than SPH-PASMCs. Furthermore, K V currents were significantly diminished in PPH-PASMCs. Because of the dysfunctional K V channels, the response of [Ca 2ϩ ] cyt to the K V channel blocker 4-aminopyridine was significantly attenuated in PPH-PASMCs, whereas the response to 60 mmol/L K ϩ was comparable to that in SPH-PASMCs. Conclusions-These results indicate that K V channel function in PPH-PASMCs is inhibited compared with SPH-PASMCs.
P rimary pulmonary hypertension (PPH) is a rare disease with an incidence of 1 to 2 per million per year that is characterized hemodynamically by elevated pulmonary vascular resistance, leading to progressive right heart failure and death. The predominant pathophysiological and pathological features include vasoconstriction, vascular remodeling (medial and intimal proliferation), vascular injury (induced by shear stress, ischemia, and inflammation), and in situ thrombosis. [1] [2] [3] Impaired endothelium-dependent pulmonary vasorelaxation, increased endothelin-1 synthesis, and imbalanced secretion of vasoactive prostanoids have been implicated in the development of both PPH and secondary pulmonary hypertension (SPH). [4] [5] [6] [7] However, several lines of evidence indicate that intrinsic abnormalities of pulmonary vascular smooth muscle are present in PPH and may be important in its pathogenesis. Medial hypertrophy, suggesting a stimulus for vasoconstriction, is the earliest and most consistent pathological finding of PPH, 1, 2, 8, 9 and smooth muscle stretch induced by vasoconstriction is a promoter of smooth muscle cell hypertrophy and hyperplasia. 10 Pulmonary arteries from patients with PPH tend to have more smooth muscle hypertrophy compared with vessels from patients with SPH. 11 Additionally, vascular rings from PPH patients are more sensitive to vasoconstrictors than rings from normal subjects, 12 and patients with PPH tend to be more responsive to acute vasodilator than patients with SPH. 2, 8 Approximately 26% of PPH patients exhibit significant and sustained reductions in pulmonary artery pressure and vascular resistance in response to Ca 2ϩ channel blockers, 13 suggesting that elevated cytoplasmic free Ca 2ϩ concentration ([Ca 2ϩ ] cyt ) in pulmonary arterial smooth muscle cells (PASMCs) is involved, at least in part, in the development and maintenance of PPH.
A rise in [Ca 2ϩ ] cyt in PASMCs is a major trigger for vasoconstriction and an important stimulus for smooth muscle hypertrophy. 14 -16 Membrane potential (E m ) controls the function of sarcolemmal voltage-gated Ca 2ϩ channels and is thus a key determinant of [Ca 2ϩ ] cyt and pulmonary vascular tone. 14 The resting E m in PASMCs is regulated by the K 
Methods

Subjects
The clinical and hemodynamic characteristics of the 21 subjects from whom lung tissue was obtained are shown in the Table. The diagnosis of PPH was established clinically in 5 patients on the basis of the criteria used in the National Institutes of Health Registry on PPH 1 and confirmed histopathologically. Ten subjects had pulmonary hypertension resulting from known causes (SPH) (Table) . Two patients undergoing lobectomy for bronchogenic carcinoma, who had no evidence of pulmonary hypertension by physical examination, ECG, echocardiogram, or pathological examination of resected lung tissue, and 4 patients with obstructive disease, who had normal pulmonary arterial pressures, were the sources of tissue for normotensive control experiments (nonpulmonary hypertension [NPH]).
Preparation and Culture of PASMCs
We used primary cultured PASMCs in this study. Lung tissue, removed from patients in the operating room, was immediately placed in cold (4°C) saline and taken to the laboratory for dissection. Muscular pulmonary arteries were incubated in Hanks' balanced salt solution (20 minutes) containing 2 mg/mL collagenase (Worthington Biochemical). The adventitia was stripped, and endothelium was removed. The remaining smooth muscle was digested with 2.0 mg/mL collagenase, 0.5 mg/mL elastase, and 1 mg/mL bovine albumin (Sigma Chemical Co) at 37°C to make a cell suspension of PASMCs. The single PASMC was resuspended, plated onto 25-mm coverslips, and incubated in a humidified atmosphere of 5% CO 2 in air at 37°C in 10% fetal bovine serum DMEM for 1 week.
Immunofluorescence Labeling
The PASMCs were stained with the membrane-permeant nucleic acid stain, 4Ј, 6Ј-diamidino-2-phenylinodole (DAPI, 5 mol/L), and the blue fluorescence emitted at 461 nm was used to estimate total cell numbers in the cultures. A specific monoclonal antibody raised against smooth muscle ␣-actin was used to evaluate cellular purity of cultures, and a secondary antibody conjugated with indocarbocyanine (Cy3) was used to display the fluorescent image (emitted at 570 nm). The cell images were processed by a MetaFluor/MetaMorph Imaging System (University Imagine); the Cy3 fluorescence was colored red and DAPI fluorescence was colored green to display images with red-green overlay.
Measurement of [Ca 2؉ ] cyt
The [Ca 2ϩ ] cyt in single PASMC was measured by use of fura-2 and quantitative fluorescence microscopy. 17 The fura-2-loaded 
Measurements of K ؉ Currents and E m
Whole-cell and single-channel K ϩ currents (I K ) were recorded with an Axopatch-1D amplifier and pClamp software (Axon Instruments) by use of patch clamp techniques ( Figure 1A through 1C) . 17 Patch pipettes (2 to 4 M⍀) were fire polished on a microforge. The currents were filtered at 1 to 2 kHz (Ϫ3 dB) and digitized at 4 to 6 kHz.
Whole-Cell I K Recording
Step-pulse protocols and data acquisition were performed by a TL-1 digital interface (Axon Instruments) coupled to a computer ( Figure  1B ). Series resistance and whole-cell capacitance were compensated for by adjustment of the internal circuitry of the amplifier. Leakage and capacitance currents were subtracted by use of the P/4 protocol in pClamp software. The normal bath (extracellular) solution contained (mmol/L) NaCl 141, KCl 4.7, MgCl 2 1.2, CaCl 2 1.8, glucose 10, and HEPES 10, pH 7.4, with 1 mol/L NaOH. The patch pipette (intracellular) solution contained (mmol/L) KCl 125, ATP 5, EGTA 10, MgCl 2 4, and HEPES 10, pH 7.2.
Single-Channel I K Measurement
For cell-attached recording ( Figure 1A ), the extracellular solution was the same as that described for whole-cell current recording. The patch pipette (extracellular) solution contained (mmol/L) KCl 135, HEPES 10, MgCl 2 1.2, glucose 10, and EGTA 10, pH 7.4. The extracellular and intracellular solutions for measuring currents in outside-out patches ( Figure 1C) were the same as those for wholecell current recording.
Membrane Potential Recording
E m in single PASMC was measured in current-clamp configuration when the cell was held at no current (Iϭ0). The extracellular and intracellular solutions were the same as those for whole-cell current recording.
Chemicals
4-Aminopyridine (4-AP, Sigma) and tetraethylammonium (TEA, Chemika Fluka) were directly dissolved in the bath superfusate on the day of use. Charybdotoxin (ChTX, Acurate) and cyclopiazonic acid (CPA, Sigma) were dissolved in water and DMSO, respectively, to make stock solutions of 100 mol/L and 20 mmol/L; aliquots of the stock solutions were diluted 1:2000 to 1:4000 to make final concentrations of 25 nmol/L and 10 mol/L. Similar dilution of DMSO alone into the bath solution was used as control and had no effect on K ϩ currents, E m , and [Ca 2ϩ ] cyt .
Statistical Analysis
Data are expressed as meanϮSE. Statistical analysis was performed by use of the unpaired Student's t test or ANOVA. Differences were considered significant when PϽ0.05.
Results
Mean pulmonary arterial pressures in SPH (46Ϯ4 mm Hg, nϭ9) and PPH (53Ϯ4 mm Hg, nϭ5) patients were comparable (Pϭ0.30) and were significantly higher than in NPH patients (19Ϯ1 mm Hg, nϭ5, PϽ0.001). Other hemodynamic parameters were comparable in SPH and PPH (Table) . Virtually all cells stained by the nucleic acid dye DAPI cross-reacted with the smooth muscle ␣-actin antibody (Figure 2) , indicating that the cultured cells were smooth muscle cells without contamination by fibroblasts and endothelial cells. Additionally, there was no apparent morphological difference between SPH-and PPH-PASMCs (Figure 2 18 Consistent with the higher resting [Ca 2ϩ ] cyt , the resting E m in PPH-PASMCs was significantly more depolarized than in SPH-PASMCs (Figure 3, inset) . E m is determined primarily by K ϩ permeability through sarcolemmal K ϩ channels. Whether the more depolarized E m in PPH-PASMCs is due to inhibited K ϩ channels was then examined by comparing K ϩ currents between SPH-and PPH-PASMCs. Figure 4B ). Because the size of the SPH-and PPH-PASMCs appeared similar (Figure 2 ), the reduced I K(V) was unlikely to be due to size-related differences in cell capacitance.
Comparison of Single-Channel I K in SPH-and PPH-PASMCs
In cell-attached membrane patches of SPH-PASMCs, a largeamplitude K Ca current and a small-amplitude I K(V) (slope conductance, 44 to 65 pS; nϭ8) were elicited by depolarization to ϩ90 mV ( Figure 5A ). The calculated slope conductances of K Ca currents are 217Ϯ8 pS (nϭ17) and 215Ϯ7 pS (nϭ9) in SPH-and PPH-PASMCs, respectively. In 44 SPH-PASMC membrane patches tested, the K Ca current was evident in 40 patches (91%), and I K(V) was apparent in 32 patches (73%) ( Figure 5B ). In contrast, in 16 PPH-PASMC membrane patches tested, K Ca current was observed in all patches (100%), but I K(V) was detectable in only 2 patches (12%), suggesting that the small-conductance I K(V) is diminished in PPH-PASMCs.
Diminished Response of [Ca
2؉ ] cyt to 4-AP in PPH-PASMCs
In excised outside-out patches, 5 mmol/L 4-AP ( Figure 6A ) had no effect on the large-conductance K Ca current, whereas 1 mmol/L TEA ( Figure 6B ) significantly inhibited the K Ca current (the steady-state open probability was decreased from 0.65 to 0.23). These results suggest that 4-AP predominantly blocks K V channels, whereas low doses of TEA selectively block K Ca channels. 20 Application of 1 mmol/L TEA ( Figure 6C ) or 25 nmol/L ChTX did not affect [Ca 2ϩ ] cyt (by 3Ϯ1 nmol/L, nϭ10, and 1Ϯ1 nmol/L, nϭ17, respectively) in SPH-PASMCs. The K ATP channel blocker glibenclamide (10 mol/L) also had no effect on [Ca 2ϩ ] cyt (by 2Ϯ1 nmol/L, nϭ17). These results suggest that K Ca and K ATP channels may be relatively inactive under resting conditions because of low [Ca 2ϩ ] cyt (50 to 100 nmol/L) and a high concentration of intracellular ATP (1 to 3 mmol/L). 20 The K V channel blocker 4-AP, however, reversibly increased [Ca 2ϩ ] cyt in PASMCs from NPH and SPH patients ( Figure 7A ). This effect was apparently caused by membrane depolarization induced by reduction of I K(V) , because a similar effect could be induced by 60 mmol/L K ϩ (which shifts the K ϩ equilibrium potential to Ϫ21 mV) ( Figure 7B ). In contrast, the 4-AP-induced increase in [Ca 2ϩ ] cyt was significantly attenuated in PPH-PASMCs ( Figure 7A and 7C) . The effect of 60 mmol/L K ϩ on [Ca 2ϩ ] cyt was similar in cells from SPH and PPH patients ( Figure 7B and 7D ).
Discussion
The absence of a suitable animal model of PPH and its rarity have hampered progress in clarifying the pathogenesis of PPH. By obtaining pulmonary vascular tissue from patients with both SPH and PPH, we were able to compare and contrast at a cellular level the mechanisms underlying this disease. Our results demonstrate that compared with SPHPASMCs, PPH-PASMCs have (1) a higher resting [Ca 2ϩ ] cyt and a more depolarized resting E m , (2) an inhibited I K(V) , and (3) a diminished response of [Ca 2ϩ ] cyt to the K V channel blocker 4-AP. These observations indicate that the K V channels are dysfunctional PPH-PASMCs. The resultant membrane depolarization and increased [Ca 2ϩ ] cyt may play a pivotal role in vasoconstriction and possibly vascular proliferation, which are important components of the pathogenesis of PPH. . 17, 19, 20 The transient I K(V) , which resembles A-type K ϩ current, is involved mainly in regulating the duration of action potential, whereas the steady-state I K(V) , which resembles slowly inactivating or noninactivating delayed rectifier K ϩ current, plays an important role in governing resting E m . In PASMCs, inhibition of I K(V) raised [Ca 2ϩ ] cyt by depolarizing the cell membrane and increased pulmonary arterial pressure, [17] [18] [19] [20] whereas inhibition of K Ca currents and K ATP currents had no effects on resting E m , [Ca 2ϩ ] cyt , or pulmonary vascular tone. 17, 19 These results suggest that in PASMCs, I K(V) is a major determinant of E m and [Ca 2ϩ ] cyt at rest 17 and is an important contributor to the maintenance of basal pulmonary vascular tone. 19 Weir et al 21 recently demonstrated that the anorexic agents aminorex and fenfluramine inhibited the 4-AP-sensitive I K , caused membrane depolarization, and increased pulmonary arterial pressure. Because appetite suppressant use has been implicated in the development of PPH in some patients who take these drugs, 22 it is possible that a predisposition to the development of PPH based on the function of PASMC K V channels may exist in susceptible individuals.
Endogenous K V channels turn over very rapidly; the half-lives of the channel mRNA and protein are 0.5 and 4 hours, respectively. 23 The short half-life of the K V channels suggests that the cells undergo rapid exchange of channel mRNAs. Compared with SPH-PASMCs, the mRNA level of K V 1.5 (a delayed rectifier K V channel ␣ subunit) is significantly attenuated in PPH-PASMCs. 24 The decreased K v 1.5 mRNA expression would reduce the number of the functional K V channels and decrease K V current availability. Thus, 1 mechanism involved in the attenuated I K(V) in PPH-PASMCs is inhibited gene transcription and/or reduced mRNA stability of K V channels.
[ ] SR may thus be responsible for the augmented agonist-mediated pulmonary vasoconstriction in PPH patients. 12 A rise in cytosolic [Ca 2ϩ ], in addition to triggering cell contraction, can rapidly (within 50 to 300 ms) increase nuclear [Ca 2ϩ ] and promote cell proliferation by moving quiescent cells into the cell cycle and by propelling the proliferating cells through mitosis. 15, 16, 25 Thus, increased [Ca 2ϩ ] cyt may also play a pivotal role in the hypertrophy of small pulmonary arteries and muscularization of pulmonary arterioles, which are characteristic of PPH.
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Possible Origin of PPH: Involvement of Dysfunctional K V Channels
A variety of endothelium-derived vasoactive substances, such as nitric oxide, endothelium-derived hyperpolarizing factor (epoxides), prostacyclin, and endothelin, 26 -29 exert their effects in part through alteration of ion channel function in PASMCs. Thus, an impairment of endothelium-dependent pulmonary relaxation, an imbalance in the ratio of vasoconstrictors and vasodilators, and a dysfunctional K V channel in PASMCs may contribute to the development or progression of PPH. We postulate that the early stages of PPH are characterized by pulmonary vasoconstriction resulting from dysfunctional K V channels (Figure 8 ), which lead to E m depolarization and an increase in [Ca 2ϩ ] cyt in PASMCs. Subsequently, impaired endothelium-dependent vasodilation and elevated [Ca 2ϩ ] cyt potentiate vasoconstriction and eventually lead to vascular remodeling. Altered secretion of endothelium-derived constricting and relaxing factors further contributes to vasoconstriction and vascular wall thickening. Ultimately, dynamic vasoconstriction is replaced by extensive vascular remodeling. 
